BactiQuant A/S (9JX) Financial Statements
BactiQuant A/S Financial Overview
BactiQuant A/S's market cap is currently $13.99M. The company's EPS TTM is $-0.35; its P/E ratio is -7.22; BactiQuant A/S has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 8.32M | $ 7.18M | $ 12.30M | $ 12.39M | $ 8.36M |
| Gross Profit | $ -11.44M | $ -11.58M | $ -755.71K | $ -12.79M | $ -11.95M |
| Operating Income | $ -12.52M | $ -12.64M | $ -10.90M | $ -13.68M | $ -12.68M |
| EBITDA | $ -12.01M | $ -11.71M | $ -11.12M | $ -11.91M | $ -12.46M |
| Net Income | $ -13.83M | $ -13.72M | $ -13.10M | $ -14.18M | $ -13.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.87M | $ 853.45K | $ 11.82M | $ 3.62M | $ 10.44M |
| Total Assets | $ 28.07M | $ 14.70M | $ 25.50M | $ 23.18M | $ 24.52M |
| Total Debt | $ 8.22M | $ 10.79M | $ 8.44M | $ 5.88M | $ 1.55M |
| Net Debt | $ -9.64M | $ 9.93M | $ -3.39M | $ 1.10M | $ -8.89M |
| Total Liabilities | $ 10.81M | $ 14.01M | $ 11.09M | $ 8.87M | $ 3.46M |
| Stockholders' Equity | $ 17.26M | $ 689.23K | $ 14.41M | $ 14.31M | $ 21.06M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.51M | $ -12.97M | $ -8.70M | $ -17.85M | $ -15.44M |
| Operating Cash Flow | $ -10.51M | $ -12.63M | $ -8.16M | $ -17.10M | $ -13.25M |
| Investing Cash Flow | $ -9.00K | $ -343.98K | $ -581.80K | $ -767.61K | $ -2.59M |
| Financing Cash Flow | $ 27.53M | $ 2.00M | $ 16.95M | $ 11.04M | $ 25.61M |
Currency in DKK
